<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34041295</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2312-0541</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>ERJ open research</Title><ISOAbbreviation>ERJ Open Res</ISOAbbreviation></Journal><ArticleTitle>Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">00141-2021</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/23120541.00141-2021</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">It remains unknown whether and to what extent members of online "long COVID" peer support groups remain symptomatic and limited over time. Therefore, we aimed to evaluate symptoms in members of online long COVID peer support groups up to 6&#x2005;months after the onset of coronavirus disease 2019 (COVID-19)-related symptoms.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Demographics, symptoms, health status, work productivity, functional status and health-related quality of life were assessed about 3 and 6&#x2005;months after the onset of COVID-19-related symptoms in members of online long COVID peer support groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Data from 239 patients with a confirmed COVID-19 diagnosis (83% women; median (interquartile range) age 50 (39-56) years) were analysed. During the infection, a median (interquartile range) of 15 (11-18) symptoms was reported, which was significantly lower 3 and 6&#x2005;months later: 6 (4-9) and 6 (3-8), respectively (p&lt;0.05). From 3 to 6&#x2005;months follow-up, the proportion of patients without symptoms increased from 1.3% to only 5.4% (p&lt;0.001). Patients also reported a significantly improved work productivity (work absenteeism and presenteeism: 73% <i>versus</i> 52% and 66% <i>versus</i> 60%, respectively), self-reported good health (9.2% <i>versus</i> 16.7%), functional status (mean&#xb1;sd Post-COVID-19 Functional Status scale: 2.4&#xb1;0.9 <i>versus</i> 2.2&#xb1;1.0) and health-related quality of life (all p&lt;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Although patients with confirmed COVID-19, who were all members of online long COVID peer support groups, reported significant improvements in work productivity, functional status and quality of life between 3 and 6&#x2005;months follow-up, these data clearly highlight the long-term impact of COVID-19, as approximately 6&#x2005;months after the onset of COVID-19-related symptoms a large proportion still experienced persistent symptoms, a moderate-to-poor health, moderate-to-severe functional limitations, considerable loss in work productivity, and/or an impaired quality of life. Action is needed to improve the management and healthcare of these patients.</AbstractText><CopyrightInformation>Copyright &#xa9;The authors 2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vaes</LastName><ForeName>Anouk W</ForeName><Initials>AW</Initials><Identifier Source="ORCID">0000-0002-4136-1553</Identifier><AffiliationInfo><Affiliation>Dept of Research and Development, Ciro, Horn, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Go&#xeb;rtz</LastName><ForeName>Yvonne M J</ForeName><Initials>YMJ</Initials><AffiliationInfo><Affiliation>Dept of Research and Development, Ciro, Horn, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nutrim School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Herck</LastName><ForeName>Maarten</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3333-6964</Identifier><AffiliationInfo><Affiliation>Dept of Research and Development, Ciro, Horn, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nutrim School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>REVAL - Rehabilitation Research Center, BIOMED - Biomedical Research Institute, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machado</LastName><ForeName>Felipe V C</ForeName><Initials>FVC</Initials><AffiliationInfo><Affiliation>Dept of Research and Development, Ciro, Horn, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nutrim School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meys</LastName><ForeName>Roy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Dept of Research and Development, Ciro, Horn, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nutrim School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delbressine</LastName><ForeName>Jeannet M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Dept of Research and Development, Ciro, Horn, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houben-Wilke</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dept of Research and Development, Ciro, Horn, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaffron</LastName><ForeName>Swetlana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4540-0732</Identifier><AffiliationInfo><Affiliation>Viscovery Software GmbH, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>Dieter</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Biomax Informatics AG, Planegg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burtin</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>REVAL - Rehabilitation Research Center, BIOMED - Biomedical Research Institute, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posthuma</LastName><ForeName>Rein</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0015-0116</Identifier><AffiliationInfo><Affiliation>Dept of Research and Development, Ciro, Horn, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nutrim School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Loon</LastName><ForeName>Nicole P H</ForeName><Initials>NPH</Initials><AffiliationInfo><Affiliation>Dept of Research and Development, Ciro, Horn, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Internal Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franssen</LastName><ForeName>Frits M E</ForeName><Initials>FME</Initials><Identifier Source="ORCID">0000-0002-1633-6356</Identifier><AffiliationInfo><Affiliation>Dept of Research and Development, Ciro, Horn, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nutrim School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajian</LastName><ForeName>Bita</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Dept of Research and Development, Ciro, Horn, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nutrim School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simons</LastName><ForeName>Sami O</ForeName><Initials>SO</Initials><Identifier Source="ORCID">0000-0002-4296-5076</Identifier><AffiliationInfo><Affiliation>Nutrim School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Boven</LastName><ForeName>Job F M</ForeName><Initials>JFM</Initials><Identifier Source="ORCID">0000-0003-2368-2262</Identifier><AffiliationInfo><Affiliation>Dept of Clinical Pharmacy and Pharmacology, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klok</LastName><ForeName>Frederikus A</ForeName><Initials>FA</Initials><Identifier Source="ORCID">0000-0001-9961-0754</Identifier><AffiliationInfo><Affiliation>Dept of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spaetgens</LastName><ForeName>Bart</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Dept of Internal Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinxt</LastName><ForeName>Claire M H</ForeName><Initials>CMH</Initials><AffiliationInfo><Affiliation>Dept of Internal Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Limmie Y L</ForeName><Initials>LYL</Initials><AffiliationInfo><Affiliation>Dept of Internal Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wesseling</LastName><ForeName>Geertjan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Nutrim School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spies</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Lung Foundation Netherlands, Amersfoort, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vijlbrief</LastName><ForeName>Herman</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Lung Foundation Netherlands, Amersfoort, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van 't Hul</LastName><ForeName>Alex J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-5514-2327</Identifier><AffiliationInfo><Affiliation>Dept of Pulmonary Disease, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janssen</LastName><ForeName>Daisy J A</ForeName><Initials>DJA</Initials><Identifier Source="ORCID">0000-0002-1827-9869</Identifier><AffiliationInfo><Affiliation>Dept of Research and Development, Ciro, Horn, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Health Services Research, Care and Public Health Research Institute, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spruit</LastName><ForeName>Martijn A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-3822-7430</Identifier><AffiliationInfo><Affiliation>Dept of Research and Development, Ciro, Horn, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nutrim School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dept of Respiratory Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ERJ Open Res</MedlineTA><NlmUniqueID>101671641</NlmUniqueID><ISSNLinking>2312-0541</ISSNLinking></MedlineJournalInfo><CoiStatement>Conflict of interest: A.W. Vaes has nothing to disclose. Conflict of interest: Y.M.J. Go&#xeb;rtz has nothing to disclose. Conflict of interest: M. Van Herck has nothing to disclose. Conflict of interest: F.V.C. Machado has nothing to disclose. Conflict of interest: R. Meys has nothing to disclose. Conflict of interest: J.M. Delbressine has nothing to disclose. Conflict of interest: S. Houben-Wilke has nothing to disclose. Conflict of interest: S. Gaffron has nothing to disclose. Conflict of interest: D. Maier reports Biomax provides data management and analysis services to CIRO. Conflict of interest: C. Burtin has nothing to disclose. Conflict of interest: R. Posthuma has nothing to disclose. Conflict of interest: N.P.H. van Loon has nothing to disclose. Conflict of interest: F.M.E. Franssen reports grants and personal fees from AstraZeneca, and personal fees from Boehringer Ingelheim, Chiesi, GSK and TEVA, outside the submitted work. Conflict of interest: B. Hajian has nothing to disclose. Conflict of interest: S.O. Simons reports personal fees from AstraZeneca and grants from GSK, outside the submitted work. Conflict of interest: J.F.M. Van Boven has nothing to disclose. Conflict of interest: F.A. Klok reports grants from Bayer, Bristol Meyer Squibb, Boehringer Ingelheim, MSD, Daiichi-Sankyo, Actelion, the Dutch Thrombosis Association, the Dutch Heart Foundation, and the Netherlands Organisation for Health Research and Development, outside the submitted work. Conflict of interest: B. Spaetgens has nothing to disclose. Conflict of interest: C.M.H. Pinxt has nothing to disclose. Conflict of interest: L.Y.L. Liu has nothing to disclose. Conflict of interest: G. Wesseling has nothing to disclose. Conflict of interest: Y. Spies has nothing to disclose. Conflict of interest: H. Vijlbrief has nothing to disclose. Conflict of interest: A.J. Van &#x2019;t Hul has nothing to disclose. Conflict of interest: D.J.A. Janssen reports personal fees from AstraZeneca, Boehringer Ingelheim and Novartis, outside the submitted work. Conflict of interest: M.A. Spruit reports grants from Lung Foundation Netherlands and Stichting Astma Bestrijding, and grants and personal fees from AstraZeneca and Boehringer Ingelheim, outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34041295</ArticleId><ArticleId IdType="pmc">PMC8012818</ArticleId><ArticleId IdType="doi">10.1183/23120541.00141-2021</ArticleId><ArticleId IdType="pii">00141-2021</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, et al. . Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 2020; 6: 00542-2020. doi:10.1183/23120541.00542-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324: 603&#x2013;605. doi:10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, et al. . Management of post-acute COVID-19 in primary care. BMJ 2020; 370: m3026. doi:10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AW, Shah AS, Johnston JC, et al. . Patient-reported outcome measures after COVID-19: a prospective cohort study. Eur Respir J 2020; 56: 2003276. doi:10.1183/13993003.03276-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03276-2020</ArticleId><ArticleId IdType="pmc">PMC7530908</ArticleId><ArticleId IdType="pubmed">33008936</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Cruz RF, Waller MD, Perrin F, et al. . Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res 2021; 7: 00655-2020. doi:10.1183/23120541.00655-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00655-2020</ArticleId><ArticleId IdType="pmc">PMC7585700</ArticleId><ArticleId IdType="pubmed">33575312</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. medRxiv 2020; preprint [10.1101/2020.10.19.20214494].</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.19.20214494</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397: 220&#x2013;232. doi:10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, et al. . Persistent symptoms 1.5-6&#x2005;months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax 2021; 76: 405&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al. . Long COVID in the Faroe Islands &#x2013; a longitudinal study among non-hospitalized patients. Clin Infect Dis 2020; in press [10.1093/cid/ciaa1792]. doi:10.1093/cid/ciaa1792</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes AW, Machado FVC, Meys R, et al. . Care dependency in non-hospitalized patients with COVID-19. J Clin Med 2020; 9: 2946. doi:10.3390/jcm9092946</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092946</ArticleId><ArticleId IdType="pmc">PMC7564703</ArticleId><ArticleId IdType="pubmed">32932582</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B, Peters JB, Brink M, et al. . Comprehensive health assessment three months after recovery from acute COVID-19. Clin Infect Dis 2020; in press [10.1093/cid/ciaa1750]. doi:10.1093/cid/ciaa1750</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1750</ArticleId><ArticleId IdType="doi">10.1093/cid/ciaa1750</ArticleId><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Perego E, Callard F, Stras L, et al. . Why the Patient-Made Term &#x2018;Long Covid' is needed. Wellcome Open Res 2020; 5: 224. doi:10.12688/wellcomeopenres.16307.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.16307.1</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institue for Health and Care Excellence. COVID-19 guideline: management of the long-term effects of COVID-19. www.nice.org.uk/guidance/gid-ng10179/documents/final-scope
Date last updated: 19 October 2020; date last accessed: 2 March 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 993&#x2013;998. doi:10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al. . Persistent symptoms after Covid-19: qualitative study of 114 long Covid patients and draft quality criteria for services. medRxiv 2020; preprint [10.1101/2020.10.13.20211854].</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.13.20211854</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Assaf G, Davis H, McCorkell L, et al. . 
An analysis of the prolonged COVID-19 symptoms survey by patient-led research team. 2020. https://patientresearchcovid19.com/research/report-1/
Date last updated: 11 May 2020; date last accessed: 15 November 2020.</Citation></Reference><Reference><Citation>Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993; 4: 353&#x2013;365. doi:10.2165/00019053-199304050-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00019053-199304050-00006</ArticleId><ArticleId IdType="pubmed">10146874</ArticleId></ArticleIdList></Reference><Reference><Citation>Brakema EA, Tabyshova A, van der Kleij R, et al. . The socioeconomic burden of chronic lung disease in low-resource settings across the globe - an observational FRESH AIR study. Respir Res 2019; 20: 291. doi:10.1186/s12931-019-1255-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-019-1255-z</ArticleId><ArticleId IdType="pmc">PMC6925865</ArticleId><ArticleId IdType="pubmed">31864411</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon GJAM, Barco S, et al. . The Post-COVID-19 Functional Status (PCFS) Scale: a tool to measure functional status over time after COVID-19. Eur Respir J 2020; 56: 2001494. doi:10.1183/13993003.01494-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado FVC, Meys R, Delbressine JM, et al. . Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19. Health Qual Life Outcomes 2021; 19: 40. doi:10.1186/s12955-021-01691-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01691-2</ArticleId><ArticleId IdType="pmc">PMC7856622</ArticleId><ArticleId IdType="pubmed">33536042</ArticleId></ArticleIdList></Reference><Reference><Citation>Versteegh MM, Vermeulen KM, Evers SMAA, et al. . Dutch tariff for the five-level version of EQ-5D. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes. Research 2016; 19: 343&#x2013;352. doi:10.1016/j.jval.2016.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2016.01.003</ArticleId><ArticleId IdType="pubmed">27325326</ArticleId></ArticleIdList></Reference><Reference><Citation>EQ-5D. https://euroqol.org/eq-5d-instruments/eq-5d-5l-about</Citation></Reference><Reference><Citation>Grochtdreis T, Dams J, Konig HH, et al. . Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set. Eur J Health Econ 2019; 20: 933&#x2013;944. doi:10.1007/s10198-019-01054-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10198-019-01054-1</ArticleId><ArticleId IdType="pubmed">31030292</ArticleId></ArticleIdList></Reference><Reference><Citation>Woloshin S, Patel N, Kesselheim AS. False negative tests for SARS-CoV-2 infection - challenges and implications. N Engl J Med 2020; 383: e38. doi:10.1056/NEJMp2015897</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2015897</ArticleId><ArticleId IdType="pubmed">32502334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamdar BB, Suri R, Suchyta MR, et al. . Return to work after critical illness: a systematic review and meta-analysis. Thorax 2020; 75: 17&#x2013;27. doi:10.1136/thoraxjnl-2019-213803</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2019-213803</ArticleId><ArticleId IdType="pmc">PMC7418481</ArticleId><ArticleId IdType="pubmed">31704795</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriatopoulou M, Korompoki E, Fotiou D, et al. . Organ-specific manifestations of COVID-19 infection. Clin Exp Med 2020; 20: 493&#x2013;506. doi:10.1007/s10238-020-00648-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-020-00648-x</ArticleId><ArticleId IdType="pmc">PMC7383117</ArticleId><ArticleId IdType="pubmed">32720223</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, et al. . Extrapulmonary manifestations of COVID-19. Nat Med 2020; 26: 1017&#x2013;1032. doi:10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Davido B, Seang S, Tubiana R, et al. . Post-COVID-19 chronic symptoms: a postinfectious entity? Clin Microbiol Infect 2020; 26: 1448&#x2013;1449. doi:10.1016/j.cmi.2020.07.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.028</ArticleId><ArticleId IdType="pmc">PMC7376333</ArticleId><ArticleId IdType="pubmed">32712242</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Schiabor Barrett KM, Riffle S, et al. . Long-term COVID-19 symptoms in a large unselected population. medRxiv 2020; preprint [10.1101/2020.10.07.20208702].</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.07.20208702</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Wu J, Hao S, et al. . Long term outcomes in survivors of epidemic Influenza A (H7N9) virus infection. Sci Rep 2017; 7: 17275. doi:10.1038/s41598-017-17497-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17497-6</ArticleId><ArticleId IdType="pmc">PMC5722861</ArticleId><ArticleId IdType="pubmed">29222500</ArticleId></ArticleIdList></Reference><Reference><Citation>Herridge MS. Recovery and long-term outcome in acute respiratory distress syndrome. Crit Care Clin 2011; 27: 685&#x2013;704. doi:10.1016/j.ccc.2011.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2011.04.003</ArticleId><ArticleId IdType="pubmed">21742223</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins RO, Weaver LK, Collingridge D, et al. . Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. Am J Respir Crit Care Med 2005; 171: 340&#x2013;347. doi:10.1164/rccm.200406-763OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200406-763OC</ArticleId><ArticleId IdType="pubmed">15542793</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>